FindTrial
Sign In

The role of NOS1AP and its signaling pathway regulation in the development of diabetes

The role of NOS1AP and its signaling pathway regulation in the development of diabetes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016376
Enrollment
Unknown
Registered
2018-05-28
Start date
2018-05-25
Completion date
Unknown
Last updated
2018-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, NAFLD

Interventions

Case series:Nil

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Age:20-79 years old; 2. without other endocrine diseases.

Exclusion criteria

Exclusion criteria: Type 1 diabetes, women in pregency or lactation.

Design outcomes

Primary

MeasureTime frame
expression of NOS1AP/NOS;—

Countries

China

Contacts

Public ContactChen WANG

Shanghai Sixth People's Hospital

wangchen@sjtu.edu.cn+86 18930177004

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026